Dr. Cindy Leissinger

Pediatric Hematology Oncology
1415 Tulane Ave, 
New Orleans, LA 
1415 Tulane Ave, 
New Orleans, LA 
OverviewInsuranceLocationsClinical Research

Overview

Cindy Leissinger is a Pediatric Hematologist Oncology provider in New Orleans, Louisiana. Dr. Leissinger is rated as an Experienced provider by MediFind in the treatment of Purpura. Her top areas of expertise are Hemophilia A, Blood Clots, Hemophilia B, and Von Willebrand Disease (VWD).

Her clinical research consists of co-authoring 56 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Specialist in LA
Hospital Affiliations
East Jefferson General Hospital
University Medical Center New Orleans
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
1415 Tulane Ave, New Orleans, LA 70112
Other Locations
ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
2000 Canal St, New Orleans, LA 70112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An in Vitro Pilot Study of the Role of Factor IX as an Alternative to Bypassing Agents in the Treatment of Breakthrough Bleeds in Patients With Hemophilia A and Inhibitors Treated With Emicizumab.
An in Vitro Pilot Study of the Role of Factor IX as an Alternative to Bypassing Agents in the Treatment of Breakthrough Bleeds in Patients With Hemophilia A and Inhibitors Treated With Emicizumab.
Enrollment Status: Completed
Publish Date: January 20, 2025
Intervention Type: Drug
Study Phase: Early Phase 1

56 Total Publications

Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk.
Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 30, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leissinger's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile